China-based Sino Medical Sciences Technology Inc. (SHA: 688108) has announced receiving market approval from the National Medical Products Administration (NMPA) for its non-compliant balloon dilation catheter. This approval marks a significant step forward in the company’s efforts to enhance cardiovascular treatment options.
Product Profile
The non-compliant balloon dilation catheter is now applicable for balloon catheter dilation in autologous coronary artery or bypass stenosis to improve myocardial perfusion for atherosclerotic patients. It is also indicated for post-delivery dilation of balloon dilating stents, including both bare metal and drug-eluting stents.
Innovative Features
The product features a double-layer balloon, balancing high burst pressure and low compliance. Its structural design allows for higher balloon expansion accuracy, better tracking performance, and compression resistance, effectively preventing the guide wire from locking during surgery. Additionally, the product has a smaller outer diameter compared to similar products on the market, offering enhanced maneuverability and patient comfort.
Future Development
The NMPA approval underscores Sino Medical Sciences’ commitment to advancing innovative medical devices. By introducing this non-compliant balloon dilation catheter, the company aims to improve clinical outcomes and expand its presence in the cardiovascular device market.-Fineline Info & Tech
